Health Affairs. Aug2012, Vol. 31 Issue 8, p1822-1829. 8p.
مستخلص:
Technologies to improve diabetes care have advanced considerably with the introduction of the insulin pump and continuous glucose monitoring. These two technologies are now being joined and enhanced to create an artificial pancreas. The current study models the impact of the artificial pancreas on clinical results and costs over time, based on early results from clinical trials. The modeling shows that insurers' coverage of the cost of an artificial pancreas at a relatively early point in the life of a patient with diabetes would greatly reduce future complications of the disease and spending needed to treat such complications. Projected Medicare savings are $937 million in nominal dollars after twenty-five years. The results of this analysis support conducting a more comprehensive trial to assess the long-term impact of the artificial pancreas on glucose levels and the technology's related costs. [ABSTRACT FROM AUTHOR]
Copyright of Health Affairs is the property of Project HOPE/HEALTH AFFAIRS and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Full Text Finder